£114.26

Horizons in Cancer Research: Volume 71

Oncology

Price data last checked 182 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£114 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 549 days • 549 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 549 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £169 (277 days, 50.5%)

Price range: £114 - £169

Price levels: 6 different prices over 549 days

Description

Horizons in Cancer Research. Volume 71 begins by reviewing the histopathological features of head and neck squamous cell carcinoma and its precursor lesions, risk factors for head and neck squamous cell carcinoma including viral infection, chemical carcinogenic and ethnic predisposition. New knowledge about major pathways and signaling is also presented. Next, the clinical development of PD-1 and PD-L1 inhibitors in head and neck squamous cell carcinoma to date is reviewed with a focus on phase I-III clinical trials. The authors also discuss future considerations and strategies to optimize the benefits of this class of immunotherapeutic agents. Glioblastoma multiforme, the most deadly primary brain tumor in adults, is studied in the following chapter. Various studies show that only 3-5% of glioblastoma patients survive longer than 3 years and nearly 100% of all tumors recur due to therapy resistance. The most challenging aspect in the treatment of glioblastomas is the invasive nature of the tumor cells to the surrounding brain tissue. Current forms of treatment for glioblastoma allow for short-term survival, reflecting an urgent need for the development of a new form of treatment. The authors also present the cellular and molecular mechanisms of glioblastoma underlying the evasion of treatment, rationale for using novel therapeutics currently undergoing clinical trials, and explore promising molecular targets for the development of future therapeutics. This collection goes on to demonstrate the importance of TNF-alpha and its receptors in malignant gynecological and breast neoplasms, the immunological mechanisms in these neoplasms, and the role as possible future targets in the treatment. Information about the mechanisms of c-Myc are presented in order to update previous studies to discuss some of the current paradigms and provide a basis for future studies. c-Myc is a regulator gene that codes for a transcription factor, and it is important for many multidirectional cellular functions. In one study, the structural, energetic, spectroscopic and electronic properties of organometallic Ru(II) complexes of the general formula [(η6-arene)Ru(XY)Cl]Z (XY is N,N-(diamine), N,O- or O,O cheating ligands, Z = PF6 anion) were calculated by means of density functional theory electronic structure calculations. These complexes, adopting a piano-stool geometry, are potent anticancer agents and their anticancer activity against various types of cancers has already been investigated. In the closing contribution, the authors outline the guidelines for sentinel lymph node biopsy in the management of thin melanoma on the basis of its histogenetic features. A histogenetic conception and an uncertain malignant potential appear to be the most significant discriminants on whether or not to perform the biopsy.

Product Specifications

Format: hardcover
ASIN: 1536152072
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 14 April 2019
Listed Since: 26 January 2019

Barcode

No barcode data available

Horizons in Cancer Research: Volume 71

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Atlas of Lymphoscintigraphy and Sentinel Node Mapping: A Pictorial Case-Based Approach

Atlas of Lymphoscintigraphy and Sentinel Node Mapping: A Pictorial Case-Based Approach

Selective Sentinel Lymphadenectomy for Human Solid Cancer: 127 (Cancer Treatment and Research, 127)

McKee's Pathology of the Skin, 5e, 2 Volume Set

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Atlas of Lymphoscintigraphy and Sentinel Node Mapping: A Pictorial Case-Based Approach

The Intersection of Dermatology and Oncology, An Issue of Dermatologic Clinics (Volume 37-4) (The Clinics: Dermatology, Volume 37-4)

Oncodermatology: An Evidence-Based, Multidisciplinary Approach to Best Practices

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Ioachim's Lymph Node Pathology

Hematopathology of the Skin: Clinical & Pathological Approach

Lymphographie: Anatomie Technik Diagnostik

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)

A Pattern Approach to Lymph Node Diagnosis

Impact of Energy Balance on Cancer Disparities: 9

Handbook of Tumor Syndromes

Color Atlas of Canine and Feline Surgical Oncology

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)